Physician profile
Michael Jureller
NPI 1023461522
$2,415.73
in general payments reported to CMS, 2019-2025
15 companies · $52.77 in 2025
The $52.77 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $624 · 2022: $1,213 · 2023: $28.21 · 2024: $498 · 2025: $52.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549 · Travel and Lodging: $30.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.42 |
| Travel and Lodging | $30.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $801.65 | 2022 | |
| Davol INC. | $574.22 | 2021-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $253.18 | 2024 | Linx Reflux Management System |
| Allergan, INC. | $203.92 | 2021-2022 | |
| Abbvie INC. | $186.57 | 2021-2022 | |
| Medtronic, INC. | $103.96 | 2021-2025 | Signia |
| Fresenius Kabi USA, LLC | $79.42 | 2022 | |
| Vivus LLC | $53.98 | 2022 | |
| Potrero Medical, INC. | $32.72 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $28.51 | 2022-2023 | Caldolor |
| Heron Therapeutics, INC. | $28.07 | 2021-2023 | Zynrelef |
| Baxter Healthcare | $17.85 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $17.59 | 2021 | |
| Baudax Bio INC. | $17.25 | 2022 | |
| Eusa Pharma (US) LLC | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jureller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.